GEC-ESTRO (ACROP)-ABS-CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 03 2023
Historique:
received: 14 07 2022
revised: 23 08 2022
accepted: 13 09 2022
pubmed: 4 10 2022
medline: 4 2 2023
entrez: 3 10 2022
Statut: ppublish

Résumé

Representatives from the Gynecologic Groupe European de Curietherapie-European Society for Radiation Therapy and Oncology (GYN GEC-ESTRO), the American Brachytherapy Society (ABS), and the Canadian Brachytherapy Group (CBG) met to develop international consensus recommendations for target definitions for image-guided adaptive brachytherapy for vaginal recurrences of endometrial or cervical cancer. Seventeen radiation oncologists and 2 medical physicists participated. Before an in-person meeting each participant anonymously contoured 3 recurrent endometrial/cervical cancer cases. Participants contoured the residual gross primary tumor volume (GTV-T Consensus definitions for GTV-T This consensus provides recommendations to facilitate future collaborations for MRI-guided adaptive brachytherapy target definitions in endometrial/cervical vaginal recurrences.

Identifiants

pubmed: 36191741
pii: S0360-3016(22)03396-X
doi: 10.1016/j.ijrobp.2022.09.072
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

654-663

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Mitchell Kamrava (M)

Cedars Sinai Medical Center, Los Angeles, California. Electronic address: Mitchell.Kamrava@cshs.org.

Eric Leung (E)

Sunnybrook Odette Cancer Center, Ontario.

Francois Bachand (F)

BC Cancer, British Columbia, Canada.

Sushil Beriwal (S)

Allegheny Health Network, Pittsburgh, Pennsylvania and Varian Medical Systems, Palo Alto, California.

Cyrus Chargari (C)

Gustave Roussy Comprehensive Cancer Center, Villejuif, France.

David D'Souza (D)

London Health Sciences Centre, Ontario, Canada.

Beth Erickson (B)

Medical College of Wisconsin, Milwaukee, Wisconsin.

Lars Fokdal (L)

Aarhus University Hospital, Aarhus, Denmark.

Kathy Han (K)

Princess Margaret Cancer Centre, University Health Network, University of Toronto, Ontario, Canada.

Matthew Harkenrider (M)

Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois.

Lilie Lin (L)

MD Anderson Cancer Center, Houston, Texas.

Umesh Mahantshetty (U)

Tata Memorial Hospital, Mumbai, India.

Nicole Nesvacil (N)

Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Austria.

Ananth Ravi (A)

Sunnybrook Odette Cancer Center, Ontario.

Max Schmid (M)

Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Austria.

Eric Vigneault (E)

Centre Hospitalier Universitaire de Québec, Quebec, Canada.

Henrike Westerveld (H)

Amsterdam University Medical Centers, Amsterdam, the Netherlands.

Catheryn Yashar (C)

University of California San Diego, San Diego, California.

Remi Nout (R)

Erasmus MC Cancer Institute, University Medical Center Rotterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH